Background: Leishmania possess a unique trypanothionedependent redox metabolism with pivotal role in protection from oxidative damage and drug resistance. The cascade of trypanothione biosynthesis depends on L-cysteine as the precursor, whereas, cysteine bioavailability is itself dependent on the cysteine biosynthesis pathway which includes enzyme cysteine synthase (CS). However, despite the apparent dependency of redox metabolism on cysteine biosynthesis pathway, the role of CS in drug resistance and redox homeostasis has remained unexplored. Herein, we have attempted to investigate the role of LdCS in Amphotericin B (Amp B) sensitive vs. resistant isolates of L. donovani.
Methods & Materials: We established M1 and M2 macrophage polarization dynamics in the whole blood of active VL patients at an intervals of 7 days for four weeks until their drug treatment was complete. Monocytes were phenotypically charecterised by immunophenotyping studies for chemokine receptors CCR2, CX3CR1, CCR7 and cell adhesion molecules VCAM1, ICAM1, PECAM1. Functional charecterization includes quantitation of intracellular TNF-␣, IL-6, IL-1␤ production, gene expression level measurement of various M1, M2 markers in CD14 enriched cells from active and cured VL cases and in endemic healthy controls. Myeloperoxidase expression, phagocytosis and intracellular Leishmania parasite killing by monocytes were also examined.
Results: We found only minor changes in the frequency of M1 and M2 macrophages at the beginning and end of drug treatment, but observed several significant changes in the expression of cell surface markers (CD206, CD163) used to identify these cell subsets. In particular, we found that M2 macrophages increased in frequency and changed expression of cell surface molecules 14 days after drug treatment commenced, suggesting a potential role in tissue repair and homeostasis. We also observed significantly upregulated expression of several M2 markers (TGM2, PKM, SLC2A1) at gene level. We found reduced expression of CD14 on monocytes from active VL patients, but exacerbated TNF-␣, IL-6 and dercreased production of IL-1␤ in response to SLA/LPS stimulation, compared with the same cells from drug cured and endemic control samples. We also found decreased myeloperoxidase expression by monocytes in VL.
